A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is
Pharmaceutical Sciences and a PhD from Uppsala University. Her research focuses on pharmacometrics and development of population pharmacokinetic and pharmacodynamic models for desired effects and adverse events in a range of therapeutic areas, such as oncology, bacterial infections, schizophrenia, rheumatoid arthritis, and QT prolongation. Currently, most of her research is focused on development of PKPD-models for quantitative, longitudinal predictions of use for translation of drug effectsdoi:10.1002/psp4.12000 fatcat:23mjuhbjxjglxhizwowsrgkin4